• Factors Conditioning Health Related Quality Of Life In Patients With Psoriasis In Europe- A Systematic Review Of The Literature

    Nov 1, 2014, 00:00

  • The Development of an Integrated Ecoa Solution To Improve The Quality of Data Capture In Diabetes Clinical Trials

    Nov 1, 2014, 00:00

  • Database Analysis On Patients Using Immunobiological Drugs In A Brazilian Private Health Care Plan- A Real World Data Analysis

    Nov 1, 2014, 00:00

  • The Comparison Of Clinical Impact Between Entecavir And Tenofovir In Chronic Hbv Infection

    Nov 1, 2014, 00:00

  • Exploring Uncertainty in Economic Evaluation Of Medicines- A Review of The First Manufacturers' Submissions To the French National Authority For Health (Has)

    Nov 1, 2014, 00:00

  • Recruiting Cardiologists and Chronic Heart Patients From A Managed Physician Panel To Support Clinical Studies Phase Iii/Iv Or Health Outcome Studies

    Nov 1, 2014, 00:00

  • Individualised Growth Response Optimisation (IGRO)- A Multi-Language Software Medical Device to Predict Growth Response in Children Treated With Growth Hormone (GH)

    Nov 1, 2014, 00:00

  • Current Status and Deficiency of Hemostasis in Surgery- A Systematic Literature Review, Including Chinese Literature

    Nov 1, 2014, 00:00

  • The Effects of Gallium Chloride on Apoptosis Osteoporosis Model of Rats Caused by Tretinoin Acid

    Nov 1, 2014, 00:00

  • Snapshot of Prescribing Practice for Clopidogrel and Esomeprazole Co-Prescription and Cost Evaluation of Guidelines Application

    Nov 1, 2014, 00:00

  • Evaluating The Long-Term Cost-Effectiveness Of Liraglutide 1.2 Mg And Exenatide In Patients With Type 2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Monte-Carlo Simulation to Estimate the Health Care Costs Avoided With Fluticasone Furoate/Vilanterol Due to Exacerbation Rate Reduction in Spanish COPD Patients

    Nov 1, 2014, 00:00

  • All-Cause Mortality Validation of the Core Diabetes Model Against Predictions of the Charlson Comorbidity Index

    Nov 1, 2014, 00:00

  • Cost Effectiveness Evaluation of Canagliflozin In Combination With Metformin in the Treatment Of Type 2 Diabetes Mellitus In Poland

    Nov 1, 2014, 00:00

  • Towards Universal Health Care- A Review of the Basic Basket of Care Associated With Universal Health Care Delivery Models

    Nov 1, 2014, 00:00

  • Mean Annual Cost Of Patients Hospitalized For Chronic Hepatitis C In Fran The Hepc-Lone Study

    Nov 1, 2014, 00:00

  • Assessment of Need, Development and Implementation of Supportive Management Database for the Treatment of Poisoning Cases in a Tertiary Care Hospital

    Nov 1, 2014, 00:00

  • National Health Insurance Fund Drug Expenditure in Bulgaria, 2007-2012- Reference Based Pricing Alone or in Combination With Other Approaches to Pricing

    Nov 1, 2014, 00:00

  • Computerised Cognitive Behaviour Therapy for Depression Management- A Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Health Status in Adult Patients with Copd in Korea

    Nov 1, 2014, 00:00

  • HEALTH ECONOMIC EVALUATION OF DIAGNOSTIC AND PROGNOSTIC PREDICTION MODELS. A SYSTEMATIC REVIEW

    Nov 1, 2014, 00:00

  • Treatments Prior to and Post Percutaneous Coronary Intervention (PCI) in China

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Capsaicin 8% Patch (Qutenzatm) Compared With Pregabalin for the Treatment of Patients With Peripheral Neuropathic Pain (Pnp) In Scotland

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Evaluation of Data from the Evidence (Evidence of Interferon Dose-Response- European North American Comparative Efficacy) Study

    Nov 1, 2014, 00:00

  • The Dynamics Of Prices And Quantities Of New Drugs Under Taiwan's National Health Insurance Program

    Nov 1, 2014, 00:00

  • Pricing and Reimbursement Analysis of Bacillus Calmette-Guérin (BCG) Immunotherapy for Bladder Cancer

    Nov 1, 2014, 00:00

  • Cost and Quantity Characteristics of Medical Devices In Slovakia

    Nov 1, 2014, 00:00

  • Impact of Hypoglycemia on Discontinuing or Down-Titrating Sulfonylurea Among Type 2 Diabetes Patients Without Insulin

    Nov 1, 2014, 00:00

  • Direct Costs of Treatment of Skin Drug Reactions Induced by Antibiotics in Perspective of Public Payer and Service Provider

    Nov 1, 2014, 00:00

  • Prevention and Management of Medicine Shortages in Belgium, France and from The Perspective of the European Union

    Nov 1, 2014, 00:00

  • Comparison of the Valuation of Treatment Alternatives in Parkinson's Disease with Best-Worst Scaling, Time Trade-off and Visual Analogue Scales

    Nov 1, 2014, 00:00

  • Alzheimer's Disease- Medication Costs and Impact of Generic Substitution

    Nov 1, 2014, 00:00

  • Clinical and Cost-Effectiveness and Budget Impact of Routine Use of Bispectral Index Monitors In Theatres

    Nov 1, 2014, 00:00

  • Cost Effectiveness Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients

    Nov 1, 2014, 00:00

  • Investigating the Impact of Perspective on Weighting Qalys- a Discrete Choice Experiment

    Nov 1, 2014, 00:00

  • The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening

    Nov 1, 2014, 00:00

  • Orphan Drug Approvals In Europe- Historical Review and Trends

    Nov 1, 2014, 00:00

  • Antiepileptic Drug (AED) Treatment Sequencing in the Uk in Patients with Epilepsy- Real-Life Practice Data Using CPRD

    Nov 1, 2014, 00:00

  • Prescribing Pattern of Anti-Emetics for Prevention of Chemotherapy Induced Nausea Vomiting—An Observation of Clinical Practice Versus Standard Guidelines

    Nov 1, 2014, 00:00

  • A Network Meta-Analysis Comparing the Efficacy And Safety of Ceftobiprole and Selected Comparators in the Treatment of Hospital-Acquired Pneumonia

    Nov 1, 2014, 00:00

  • Common Illnesses Identified by Community Health Workers in the Households and Referrred to Primary Health Facilities For Care

    Nov 1, 2014, 00:00

  • Whole Exome Sequencing as a Diagnostic Tool for Complex Neurological Disorders

    Nov 1, 2014, 00:00

  • Skeletal-Related Events (SRES) Impact Significantly the Health-Related Quality of Life (HRQOL) of Chemo-Naive Men With Metastatic Castration Resistant Prostate Cancer (MCRPC)

    Nov 1, 2014, 00:00

  • Do the Us Panel Recommendations Hold for Europe? Investigating the Relation Between Quality of Life Versus Work-Status, Absenteeism and Presenteeism

    Nov 1, 2014, 00:00

  • Comparative Pharmacoeconomic Analysis of the Application of Posaconazole, Fluconazole and Itraconazole With the Purpose of Primary Prevention of Invasive Fungal Infection In Patients With Neutropenia During Chemotherapy for Acute Myelogenou ...

    Nov 1, 2014, 00:00

  • Early Nice Decision Problem Meetings- Implications For Cross-Functional Industry Teams

    Nov 1, 2014, 00:00

  • Simulating Individual Patient Level Data To Address Treatment Switching When Only Summary Data Are Available

    Nov 1, 2014, 00:00

  • Comparative Effectiveness of Treatments for Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL), Using Matching Adjusted Indirect Comparison

    Nov 1, 2014, 00:00

  • Treatment Patterns Among Type 2 Diabetes Mellitus Patients in Saudi Arabia

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Raltegravir in Hiv-Infected Treatment Naive Patients in Greece

    Nov 1, 2014, 00:00

  • A Comparison of Value for Health States Worse Than Dead Between Japan and Uk

    Nov 1, 2014, 00:00

  • Quantification of Switching Trends in the Greek Pharmaceutical Market During the Period Of Crisis

    Nov 1, 2014, 00:00

  • An Electronic Version of the Pdq-39- Acceptability To Respondents and Assessment of Alternative Response formats

    Nov 1, 2014, 00:00

  • Ivacaftor for Patients with Cystic Fibrosis- Clinical Efficacy and Cost-Effectiveness

    Nov 1, 2014, 00:00

  • C5a Receptor Antagonist Protects Mice from Uropathogenic Escherichia Coli-Induced Kidney Infection

    Nov 1, 2014, 00:00

  • Cost Analysis of two Aftercare Strategies in Chronic Continuous Intrathecal Baclofen Therapy in Patients with Intractable Spasticity

    Nov 1, 2014, 00:00

  • Patients' Preferences for Bone Metastases Treatments in Turkey

    Nov 1, 2014, 00:00

  • The Randomized Blind Start Trial- Evaluation of A New Study Design for Assessing Clinical Outcomes in Rare and Heterogeneous Patient Populations

    Nov 1, 2014, 00:00

  • Long Term Follow up of Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients- “Real-World” Data from the Island of Crete

    Nov 1, 2014, 00:00

  • Primary Pacemaker Insertion- Gender Differences In Prior Er Utilization

    Nov 1, 2014, 00:00

  • Influenza Vaccination in China Among the Urban Population and High-Risk Groups

    Nov 1, 2014, 00:00

  • Impact of Health Policy Changes on the Growth Locally Manufactured and Imported Pharmaceutical Markets of Top Selling Atc1 Phramaceutical Group (Alimentary and Metabolism (A0) In Turkey

    Nov 1, 2014, 00:00

  • What The English Could Learn From The Irish- Making The Nice Approval Process More Cost-Effective

    Nov 1, 2014, 00:00

  • Impact of Maternal Education on Child Immunization Propensity in China

    Nov 1, 2014, 00:00

  • An Evidence-Based Model Design to Inform the Cost-Effectiveness Evaluation of Primary Endocrine Therapy And Surgery for Older Women with Primary Breast Cancer

    Nov 1, 2014, 00:00

  • Place Of Residence And Employment Status After Stroke

    Nov 1, 2014, 00:00

  • A Real-World Characterization of Patients With “Moderate-To-Severe” Systemic Lupus Erythematosus

    Nov 1, 2014, 00:00

  • A Comparison of The Reliability and Validity of the Four-Item and Six-Item NISCI Symptom Summary Scores

    Nov 1, 2014, 00:00

  • Economic Evaluation of Catheter-Based Renal Denervation for Patients with Resistant Hypertension in Korea

    Nov 1, 2014, 00:00

  • Economic Evaluation of the Use of an Infant Formula Based on Partially Hydrolyzed Serum Protein as Compared With a Standard Whole Cow's Milk Formula for Prevention of Atopic Dermatitis in Children Under 3 Years Old

    Nov 1, 2014, 00:00

  • Assessment of Utilities in Japan- Data Availability and Methodology

    Nov 1, 2014, 00:00

  • Cost Of Diabetes Related Chronic Complication In South Korea 2011

    Nov 1, 2014, 00:00

  • Prescribing Patterns and Treatment Outcomes in North Indian Female Patients with Chronic Low Back Pain

    Nov 1, 2014, 00:00

  • Comparing the Equivalence of Eq-5d-5l Across Different Modes of Administration

    Nov 1, 2014, 00:00

  • Efficacy and Safety of Human Insulin Versus Animal Insulin Among Patients with Diabetes in China- A Meta-Analysis

    Nov 1, 2014, 00:00

  • Association of Diabetes and Cancer Diagnosis in Primary Care Practices in France

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of 1-Year Adjuvant Trastuzumab Therapy of Early-Stage Her2-Positive Breast Cancer

    Nov 1, 2014, 00:00

  • Budget Impact Of The Introduction Of New Oral Anticoagulants (Noac) For No Valve Atrial Fibrillation (Nvaf) In Extremadura

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Palivizumab Use in High Risk Children From Brazilian Health System Perspective

    Nov 1, 2014, 00:00

  • Correlation Between End-of-Life Status of A Treatment And Likelihood of A Patient Access Scheme in The Setting of A Nice Review in The UK

    Nov 1, 2014, 00:00

  • Clinical Research for the Effectiveness and Economic Value of Qinxitong in the Patients with Ra in China

    Nov 1, 2014, 00:00

  • Health Care Resource Use and Cost Of Multiple Sclerosis in Slovakia- Results from the National Cross-Sectional Study

    Nov 1, 2014, 00:00

  • Modeling to Predict Severe Maternal Morbidity Based on 33993 Deliveries of Registered Study in China

    Nov 1, 2014, 00:00

  • A Study To Assess Disease Progression To Esrd Within A Year In Patients With Advanced Ckd

    Nov 1, 2014, 00:00

  • Economic Impact of Clinical Researches to the Research Centers and Reimbursement Systems in Turkey

    Nov 1, 2014, 00:00

  • Burden of Disease Analysis of Psoriatic Arthritis In Hungary

    Nov 1, 2014, 00:00

  • Symtomatic Factors in Patients With Major Depressive Disorder (MDD)- Results from an Observational Study

    Nov 1, 2014, 00:00

  • An Epidemiologic Modeling Application To Pharmacoeconomics for Improved Health Care Planning

    Nov 1, 2014, 00:00

  • Social Aspects of HCV Treatment In Kazakhstan

    Nov 1, 2014, 00:00

  • Patients With COPD who Initiate Roflumilast in Sweden

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Certolizumab Pegol in the Management of Patients With Moderate-To-Severe Active Rheumatoid Arthritis in Greece

    Nov 1, 2014, 00:00

  • Early Switch/Early Discharge Opportunities for Hospitalized Patients with Methicillin-Resistant Staphylococcus Aureus Complicated Skin And Soft Tissue Infections- Proof Of Concept in the United Arab Emirates

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Evaluation and Burden of Illness of Acute Exacerbation of Copd in Patients in Malaysia

    Nov 1, 2014, 00:00

  • Evaluation Of The Economic Impact Of Specialist Outpatient Clinic Pharmacy Interventions In A Tertiary Institution, Singapore

    Nov 1, 2014, 00:00

  • Burden Of Cardiovascular Complications In Patients With Atrial Fibrillation In France

    Nov 1, 2014, 00:00

  • Obtaining Indirect Utilities with the Sf-6d and the Porpus-U in Prostate Cancer Patients

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Strontium Ranelate Verse Alendronate for Management of Osteoporosis Among Post-Menopausal Women in Malaysia Using A Markov Modelling Approach

    Nov 1, 2014, 00:00

  • The Impact Of The New Drug Co-Payment Scheme On Economic Evaluations In Spain

    Nov 1, 2014, 00:00

  • Investigating the use of Personalised Medicine in Cancer Trials – an Update

    Nov 1, 2014, 00:00

  • Cohort Of Hcv Patients In Italy- Sizing And Treatments In A Sample Of Italian Hepatology Centers

    Nov 1, 2014, 00:00

  • Examination of the Efficiency of Electrical Stimulation in Case of Stress and Urge Incontinence

    Nov 1, 2014, 00:00

  • What Relapsed/Refractory Cll/Mcl Treatment Outcomes Do German Patients And Physicians Find Most Important? Results from Qualitative Interviews

    Nov 1, 2014, 00:00

  • Hta Status of Biosimlars Across the UK and Ireland

    Nov 1, 2014, 00:00

  • Study of Antibiotic Prescription Pattern and Antibiotic Sesitivity in Surgery Patient in Tertiary Care Hospital

    Nov 1, 2014, 00:00

  • A Spanish Cost-Effectiveness Analysis Of Sevelamer Versus Calcium Carbonate In Nondialysis-Dependent Chronic Kidney Disease (Ckd) Patients

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Tolvaptan for the Treatment of Hyponatraemia Secondary To Syndrome Of Inappropriate Antidiuretic Hormone Secretion in Sweden

    Nov 1, 2014, 00:00

  • Effectiveness of Catheter-Based Renal Denervation for Treatment Resistant Hypertension – Results of a Systematic Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Immature Survival Data From Early Trial Termination – Theory and Hta Practice

    Nov 1, 2014, 00:00

  • Acceptance Of Telemonitoring By Health Care Professionals in Germany- A Question Of Financial Conditions

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of U100 Insulin In Egyptian Diabetic Patients

    Nov 1, 2014, 00:00

  • Challenges and Opportunities in the Malaysian Health Care System

    Nov 1, 2014, 00:00

  • Pharmaceutical Market Access in Russia- A Regional Maze?

    Nov 1, 2014, 00:00

  • An Examination of the Regulatory and Reimbursement Processes for Biobetters and Comparison With Biosimilars

    Nov 1, 2014, 00:00

  • Macular Oedema Due to Retinal Vein Occlusion Methods for the Identification of Treatment Guidelines and Areas of Unmet Clinical Needs by Means of Systematic Review

    Nov 1, 2014, 00:00

  • Prescribing Patterns and Expenditures for Otitis Media-Related Antibiotics for Children in the Texas Medicaid Program

    Nov 1, 2014, 00:00

  • Is Canagliflozin Cost-Effective Compared to Sitagliptin Across Multiple Lines of Type 2 Diabetes Mellitus (T2dm) Therapy In Ireland?

    Nov 1, 2014, 00:00

  • Aging Impact Over the National Health Cost in Extremadura Public Health Expenditure of Extremadura in the Period 2011-21

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Czech Republic

    Nov 1, 2014, 00:00

  • Characteristics of The Medicines Which Have Annual Average Highest Amount Of Sales Of Between Years 2008-2013

    Nov 1, 2014, 00:00

  • Assessing the Economic Burden and Health Care Utilization of U. S. Medicare Patients Diagnosed with Melanoma

    Nov 1, 2014, 00:00

  • Effects of A Multidisciplinary Home-Based Medication Review Program On Hospital Admissions In Older Adult Singaporeans

    Nov 1, 2014, 00:00

  • The FDA Black Box Warning Does Reduce the Use of Erythropoietin Stimulating Agents and Increases Blood Transfusions in Insured, Low Income Cancer Patients

    Nov 1, 2014, 00:00

  • Allocating Vaccine Funds for Pneumococcal Vaccination of Infants and Older Adults- A Method for Strategic Evaluation in the Netherlands

    Nov 1, 2014, 00:00

  • Impact of Simeprevir Versus Telaprevir Triple Therapy for Chronic Hcv Infection on Patient-Reported Outcomes in Prior Non-Responders to Peginterferon/Ribavirin Results from the Phase Iii Attain Study

    Nov 1, 2014, 00:00

  • Hypertension Treatment in Chronic Kidney Disease Stage 3, 4 and 5- A Hospital Based Cross-Sectional Study in Malaysia

    Nov 1, 2014, 00:00

  • Managing Congenital and Pediatric Cardiac Surgery Data Base- The Impact on Clincial Practice and Quality of Care

    Nov 1, 2014, 00:00

  • Elicitation of Health State Utilities Associated with Varying Severities of Flare in Systemic Lupus Erythematosus

    Nov 1, 2014, 00:00

  • What Is The Proportion of Patients Who Return Counter Referral Slips to the Original Referral Service For Confirmation of Arrival to the Hospital?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Ranibizumab Verse Aflibercept in Treatment of Treatment of Visual Impairment Due to Diabetic Macular Oedema (Dmo)

    Nov 1, 2014, 00:00

  • Companion Diagnostics-Targeted Therapies Pairings Model-Based Economic Evaluation- Reflection On A General Modeling Framework And Key Methodological Points

    Nov 1, 2014, 00:00

  • Discontinuities Between Health Technology Assessment (HTA) and Health Care Service Objectives of the NHS

    Nov 1, 2014, 00:00

  • The Budget Impact of Using Fidaxomicin for Hospitalised Cdi Patients from the Danish Health Care Perspective

    Nov 1, 2014, 00:00

  • Comparison of Resource use and Health Care Costs in New Initiators of Long-Acting Injectable (Lai) and Oral Second Generation Antipsychotics

    Nov 1, 2014, 00:00

  • Quality Of Hospital Food And Its Safety Assessment

    Nov 1, 2014, 00:00

  • A Double-Blind Controlled Study of the Efficacy and Safety of Long-Acting Amfepramone Treatment In Mexican Obese Patients

    Nov 1, 2014, 00:00

  • Burden Of Disease Analysis Of Ankylosing Spondylitis In Hungary

    Nov 1, 2014, 00:00

  • Efficacy, Effectiveness and the “Efficacy-To-Effectiveness Gap”- Review of the Current State of Play and Perspectives. First Results From the Imi Getreal Consortium

    Nov 1, 2014, 00:00

  • Clinical Outcomes Associated with the Use of Guideline Recommended Care in Patients Post Discharge from Chronic Obstructive Pulmonary Disease (COPD)

    Nov 1, 2014, 00:00

  • Impact of Vaccination- Health Impact and Cost-Effectiveness to Make Informed Policy Decision on the Introduction of Human Papillomavirus (Hpv) Vaccine to the National Immunization Program (Nip) in Thailand

    Nov 1, 2014, 00:00

  • Treating to the Target of Das28 2.6 in Rheumatoid Arthritis- the Impact of Efficacy on Cost Effectiveness

    Nov 1, 2014, 00:00

  • The Burden of Non-Small Cells Lung Cancer (NSCLC) in First Line (1L) Treatment- Patterns of Care and Cost of Illness

    Nov 1, 2014, 00:00

  • The Patient Voice in China- Status Quaestionis

    Nov 1, 2014, 00:00

  • Cost of a Pulmonary Arterial Hypertension-Related Hospitalization in Belgium

    Nov 1, 2014, 00:00

  • To What Extent Do Disease and Treatment Characteristics Influence Hta-Based Recommendations for A Sample of Orphan Drugs In Three Countries, and Could These Indicate Whether Orphan Drugs Have A “Special Status”?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Radical Prostatectomy, Radiation Therapy and Active Surveillance for the Treatment of Localized Prostate Cancer – A Claims Data Analysis

    Nov 1, 2014, 00:00

  • The Integrated Care Pathway for Managing Post Stroke (ICAPPS) Patients in the Community- A Cost –Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Bayesian Models for Cost-Effectiveness Analysis in the Presence of Structural Zero Costs

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Expanding the Nhs Newborn Bloodspot Screening Programme To Include Homocystinuria (Hcu), Maple Syrup Urine Disease (Msud), Glutaric Aciduria Type 1 (Ga1), Isovaleric Acidaemia (Iva), and Long-Chain Hydroxyacyl-Coa ...

    Nov 1, 2014, 00:00

  • Example of Analysis Utilizing Real World Data- Medical Cost Reduction by Advising Untreated-Hypertension Patients to Visit Doctors

    Nov 1, 2014, 00:00

  • Classification of Drugs Bringing from Abroad in Turkey According to Their Atc Codes

    Nov 1, 2014, 00:00

  • The Humanistic and Economic Burden of Partial Onset Seizures in the Europe Five and Brazil Using a Patient Survey

    Nov 1, 2014, 00:00

  • Malnutrition in Institutionalized and Community-Dwelling Older Adults in Spain- Estimates of Its Costs To the National Health System

    Nov 1, 2014, 00:00

  • An Archetype For Classification and Comparison of Hta Activities in Latin America

    Nov 1, 2014, 00:00

  • Non-Adherence And Non-Persistence Related To Glp-1 Therapy In Patients With Diabetes Mellitus Type 2 (T2dm)- Analysis of A Large German Claims-Based Dataset And Comparison To Oral Anti-Diabetics

    Nov 1, 2014, 00:00

  • Survival or Mortality- Framing of the Risk Attribute in a Discrete Choice Experiment

    Nov 1, 2014, 00:00

  • Literature Review Of Pro Measures Assessing Anticoagulant Therapy

    Nov 1, 2014, 00:00

  • Economic Analysis Of Thrombo Incode, A Clinical-Genetic Function For Assessing The Risk Of Venous Thromboembolism

    Nov 1, 2014, 00:00

  • Real-World Verse Randomised Controlled Trial Data- A Case Study On The Cost-Effectiveness Of Laparoscopic Surgery For Chronic Reflux

    Nov 1, 2014, 00:00

  • Cost-Utility of Cancer Therapies – the 'Cost' of Different Utility Generation Strategies

    Nov 1, 2014, 00:00

  • Adverse Drug Events- How Information Technology will Meet the Challenges of Pharmacovigilance

    Nov 1, 2014, 00:00

  • Public Beliefs and Attitudes about Schizophrenia, Major Depression and Psychotropic Medication in Tunisia

    Nov 1, 2014, 00:00

  • Impact of Hospital Volume on Breast Cancer Outcome- A Population Based Study in the Netherlands

    Nov 1, 2014, 00:00

  • Self-Reported Frequency and Impact of Non-Severe Hypoglycaemia in Insulin-Treated Adults in the UK

    Nov 1, 2014, 00:00

  • Severity And Functional Disability Of Patients With Occupational Contact Dermatitis- Validation Of The German Version Of The Occupational Contact Dermatitis Disease Severity Index (ODDI)

    Nov 1, 2014, 00:00

  • Cost Effectiveness of Quadrivalent Influenza Vaccine Over Trivalent Vaccine in France

    Nov 1, 2014, 00:00

  • Dapagliflozin (Forxiga®) Versus Glipizide As Add-On Therapies In Type 2 Diabetes Mellitus (T2dm); An Update of The Cost-Effectiveness Based On Long-Term Clinical Evidence From Uk Nhs Perspective

    Nov 1, 2014, 00:00

  • Prevalence-Based Measurement of the Economic Burden of Rare Diseases- Case Review To Determine the Annual Cost of Acromegaly In Italy

    Nov 1, 2014, 00:00

  • Current Status of Reimbursement Decisions for Orphan Drugs or Cancer Drugs and Implementation for Access Schemes in Korea

    Nov 1, 2014, 00:00

  • Will Governments be Able to Afford a Cancer Cure Under Current Health Economic Evaluation Methods?

    Nov 1, 2014, 00:00

  • Annual Health Insurance Cost of Breast Cancer Treatment in Hungary

    Nov 1, 2014, 00:00

  • Possibilities of Breast Cancer Prevention

    Nov 1, 2014, 00:00

  • Physicians As Double Agents In A Universal Health Care System- Evidence From Generic Pharmaceutical Adoption In Taiwan

    Nov 1, 2014, 00:00

  • Validation of The Hospital Episode Statistics Outpatient Dataset in England

    Nov 1, 2014, 00:00

  • Factors Associated With Discontinuation of Sulfonylurea Therapy In Type 2 Diabetes Patients Who Initiate Insulin

    Nov 1, 2014, 00:00

  • Estimation of Costs Associated With Cardiovascular Complications of Diabetic Patients In Madrid (Spain) Using A New Simulation Model

    Nov 1, 2014, 00:00

  • Social Media Meets Population Health- A Sentiment And Demographic Analysis of Tobacco and E-Cigarette Use Across The “Twittersphere”

    Nov 1, 2014, 00:00

  • Using an Innovative Approach to Build a Prospective Diabetes Cohort Registry of Patients With Type 2 Diabetes in Germany- DIAREG

    Nov 1, 2014, 00:00

  • Efficacy of Atropine Alone and with Glycopyrrolate Combination in Organophosphate Poisoning

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Maternal Immunisation for Pertussis in New Zealand

    Nov 1, 2014, 00:00

  • Economic Evaluation of Lapatinib in Her-2-Positive Metastatic Breast Cancer Patients in Egypt

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Portugal

    Nov 1, 2014, 00:00

  • Treatment Plan Comparison- An Observational Study of the Marche Region

    Nov 1, 2014, 00:00

  • Health Care-Associated Infection Prevalence Among Grade a Tertiary Hospitals in China- A Meta-Analysis

    Nov 1, 2014, 00:00

  • Drug Usage Analysis and Health Care Resources Consumption in Patients With Rheumatoid Arthritis

    Nov 1, 2014, 00:00

  • To Study the Treatment Pattern and Cost of Illness in Bipolar Disorder Patients in Tertiary Care Hospital in South India

    Nov 1, 2014, 00:00

  • A Mixed Methods Approach (Mma) To Understanding Men's Attitudes Toward The Management Of Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (Bph)

    Nov 1, 2014, 00:00

  • Critical Review of Cost-Effectiveness Analyses (CEA) of Prevention Strategies Against Diseases Associated with Human Papillomavirus (HPV) Infection

    Nov 1, 2014, 00:00

  • The Presence of Anxiety Among Elementary Schools Obese Children

    Nov 1, 2014, 00:00

  • State of the Art Research In Austria- Dexhelpp - Decision Support For Health Policy and Planning- Methods, Models and Technologies Based On Existing Health Care Data

    Nov 1, 2014, 00:00

  • How Does Uncertainty Around Costs And Effects Relate To Uncertainty Around Cost-Effectiveness?

    Nov 1, 2014, 00:00

  • Long-Term Outcomes of Ledipasvir/Sofosbuvir (LDV/ SOF) for the Treatment of Chronic Hepatitis C Infected (HCV) Genotype 1 Patients in the UK

    Nov 1, 2014, 00:00

  • Use of the Grace Checklist for Rating the Quality of Observational Comparative Effectiveness Research

    Nov 1, 2014, 00:00

  • Economic Impact Model of Breast Cancer Treatment at Early Stages in the Mexican Public Health Care Sector

    Nov 1, 2014, 00:00

  • Trend in Prevalence and Distribution of Diabetes Mellitus Type I and Type II in the Netherlands

    Nov 1, 2014, 00:00

  • MIGRATION OF HEALTH ECONOMICS MODELS TO WEB AND MOBILE ENVIRONMENTS. WHY SHOULD MODELS GO WEB?

    Nov 1, 2014, 00:00

  • The Costs Of Atherosclerotic And Haemorrhagic Events Associated With Acute Coronary Syndrome (Acs) In Turkey

    Nov 1, 2014, 00:00

  • Bevacizumab for Metastatic Colorectal Cancer- A Literature Review on Meta-Analyses and Cost-Effectiveness Analyses

    Nov 1, 2014, 00:00

  • Non-Treatment Specific Parameter Value Estimates- Relationship Between BMI and Utility

    Nov 1, 2014, 00:00

  • An Update of Cost-Effectiveness of Rotavirus Vaccination in Indonesia- Taking a Birth-Dose Vaccination Strategy into Account

    Nov 1, 2014, 00:00

  • Impact of Influenza B in France

    Nov 1, 2014, 00:00

  • Cost Effectiveness Of Solifenacin Compared With Oral Antimuscarinic Agents For The Treatment Of Patients With Overactive Bladder (Oab) In The Uk

    Nov 1, 2014, 00:00

  • New Meta-Analysis of Patient-Level Data on Efficacy And Hypoglycaemia with Insulin Glargine or Nph Insulin in Type 2 Diabetes Mellitus (T2DM) According to Concomitant Oral Therapy

    Nov 1, 2014, 00:00

  • Had the Individual Medical Burden of Basic Health Insurance Participants Really Been Alleviated in 2009-2012?

    Nov 1, 2014, 00:00

  • Economic Evaluation of Alzheimer

    Nov 1, 2014, 00:00

  • The Potential of (TARGETED) MR Colonography as a Screening Tool for Colorectal Cancer- A Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Medium Term Avoided Costs- High-Dose Hypoallergenic House Dust Mite Preparation Immunotherapy Verse Conventional Symptomatic Treatment

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Evaluation of Treatment With Tocilizumab in Russian Children With Systemic Juvenile Idiopathic Arthritis

    Nov 1, 2014, 00:00

  • Comparing Characteristics of Hungarian “Real Life” Patients With Participants of RCTS- First-Line Disease Modifying Therapies in Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Hepatitis a Vaccination in Indonesia

    Nov 1, 2014, 00:00

  • Reimbursed Pharmacotherapy of Metastatic Clear Cell Kidney Cancer (MCCKC) in the Czech Republic

    Nov 1, 2014, 00:00

  • The Impact of Different Levels of Clinical Pharmacist Interventions on the Therapeutic Plan and Cost Saving

    Nov 1, 2014, 00:00

  • Market Access Pathway for Medical Nutrition in Europe and The Us

    Nov 1, 2014, 00:00

  • Potential Cost-Effectiveness Of Therapeutic Drug Monitoring In Patients With Resistant Hypertension

    Nov 1, 2014, 00:00

  • Predictive Modelling for Optimal Target Population and Real-World Study Design- An Example In Mother-To-Child Transmission of HIV

    Nov 1, 2014, 00:00

  • The Costs of Major and Minor Cycling Accidents in Tasmania, Australia

    Nov 1, 2014, 00:00

  • The Epidemiology of Medical Treatment for Glaucoma and Ocular Hypertension in Germany

    Nov 1, 2014, 00:00

  • Orphan and Rare Diseases - the Payer Perspective

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Canagliflozin Compared With Liraglutide in Patients With Type 2 Diabetes Inadequately Controlled With Metformin and Sulfonylurea In France

    Nov 1, 2014, 00:00

  • Costs Associated with the Use of Enzyme-Inducing Anti-Epileptic Drugs Versus Non-Enzyme-Inducing Anti-Epileptic Drugs- A Systematic Review

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Biphasic Insulin Aspart In The Treatment Of Type 2 Diabetes Mellitus In Malaysia- A Public Payer Perspective

    Nov 1, 2014, 00:00

  • Forecasting Outpatient Pharmaceutical Expenditure for Cancer Treatment in Germany

    Nov 1, 2014, 00:00

  • Glycemic, Lipid, and Blood Pressure Control Among Individuals with Type 2 Diabetes Mellitus in Saudi Arabia

    Nov 1, 2014, 00:00

  • Estimating The Value Of Cangrelor From Eliminating Preloading In Coronary Artery Bypass Graft (Cabg) Patients

    Nov 1, 2014, 00:00

  • Health Technology Assessment and Environmental Costs- Time for Health Care To Catch Up?

    Nov 1, 2014, 00:00

  • An Observational Propensity Score-Matched Study to Evaluate Cost-Effectiveness of a Real-Time Pcr-Based Assay in Patients with Suspected Sepsisk

    Nov 1, 2014, 00:00

  • Community Pharmacists Attitude and Perceived Need Towards the Provision of Pharmaceutical Care Services- A Qualitative Approach

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Canagliflozin In The Treatment of Type 2 Diabetes Mellitus In Norway

    Nov 1, 2014, 00:00

  • Making Sense of Nice's ‘New' MTA and STA Process Guide- A Narrative Synthesis

    Nov 1, 2014, 00:00

  • Evidence for Regional Variation in the Appraisal of Individual Cancer Drugs Fund Requests

    Nov 1, 2014, 00:00

  • Health Care Resource Utilization (HCRU) In Hospitalized Febrile Neutropenia (FN) Patients Treated With Chemotherapy For Solid Tumors (ST) And Hematological Malignancies (HM) In Bulgaria

    Nov 1, 2014, 00:00

  • The Relationship Between Masked Hypertension and Obesity

    Nov 1, 2014, 00:00

  • Network Meta-Analysis With Baseline Risk Adjustment To Assess The Relative Efficacy Of Ustekinumab In Adult Patients With Active Psoriatic Arthritis

    Nov 1, 2014, 00:00

  • Analysis on Policies of Biosimilar Market in China

    Nov 1, 2014, 00:00

  • Fixed Dose Combinations of Nucleoside Reverse Transcriptase Inhibitor for Naïve Patient with Hiv Infection in Russia- Cost Comparison Analysis

    Nov 1, 2014, 00:00

  • Burden of Renal Impairment- Relative Health Care Resource use in Prostate Cancer Patients with Bone Metastases

    Nov 1, 2014, 00:00

  • Cost-Effectiveness and Cost-Utility of Granulocyte Colony-Stimulating Factors in the Primary Prophylaxis of Chemotherapy Induced Febrile Neutropenia (FN) in Breast Cancer Patients in Gree A Comparative Analysis

    Nov 1, 2014, 00:00

  • Impact of Drug Policy Regulations on the Consumption of Antihypertensive Drugs in Slovakia

    Nov 1, 2014, 00:00

  • Health Related Quality of Life and Patient Satisfaction in Colorectal Cancer Patients Treated Through Radical Surgery in Curative Intent in a Colo-Proctology Clinical Department

    Nov 1, 2014, 00:00

  • Cost Analysis In the Treatment of Patients With Systemic Lupus Erythematosus In Russian Federation

    Nov 1, 2014, 00:00

  • Relationship Between the Direct Medical Costs and Direct Non-Medical Costs of Parkinson's Disease According to Disease Severity During 4 Years of Follow-Up in Spain

    Nov 1, 2014, 00:00

  • Direct Health Care Costs Associated With Opioid-Induced Constipation

    Nov 1, 2014, 00:00

  • Direct and Indirect Cost of HCV-Related Diseases in Italy- An Incidence-Based Probabilistic Approach

    Nov 1, 2014, 00:00

  • Preliminary Steps in the Development of an Algorithm for Identifying Relapsed CLL Patients in Secondary Data

    Nov 1, 2014, 00:00

  • Long-Term Modeling of Using Manually Coded and Autocoded Blood Glucose Meters in Diabetes Treatment

    Nov 1, 2014, 00:00

  • The Impact Of Drug Price Control Policy For Diabetes Medication- A Longitudinal Analysis In Taiwan

    Nov 1, 2014, 00:00

  • The Economic Cost Of Urinary Tract Infections In The Community- Results From Ireland

    Nov 1, 2014, 00:00

  • Promoting Quality Use of Generic Medicines- Knowledge, Attitudes And Practices of Community Pharmacists in A Middle Eastern Country

    Nov 1, 2014, 00:00

  • Pattern of Antidepressant Utilization and Cost in Iran From 2007-2011 in Comparison to European and East Asian Countries and Literature Review

    Nov 1, 2014, 00:00

  • Population Health- Mental Health of us Veterans by Benefits Enrollment Status

    Nov 1, 2014, 00:00

  • Health Economic Model for Novel in Vitro Diagnostic Kit for Infective Endocarditis

    Nov 1, 2014, 00:00

  • Media Coverage of the Nice First Draft Consultation Guidance for Trastuzumab Emantansine (Kadcyla) In Breast Cancer

    Nov 1, 2014, 00:00

  • Return on Investment of Preventively Vaccinating Health Care Workers Against Pertussis- A Dutch Case Study

    Nov 1, 2014, 00:00

  • The Impact of the Information System of Medical Devices in Portugal

    Nov 1, 2014, 00:00

  • Economic Evaluation of the Fixed Dose Combination of Indacaterol/ Glycopyrromium, as a Maintenance Bronchodilator Treatment in Adult Mexican Patients With COPD

    Nov 1, 2014, 00:00

  • A Comprehensive Assessment of Early Trial Evidence in Primary Breast Cancer- How Decisions Change Over Time

    Nov 1, 2014, 00:00

  • Discrete Event Simulation For The Cost-Effectiveness Evaluation Of Pet-Ct Scans In The Diagnosis Of Conn's Disease In Hypertensive Patients

    Nov 1, 2014, 00:00

  • Impact of Demographics on Health Preferences in China- An Exploratory Analysis of China EQ-5D-5L Valuation Study

    Nov 1, 2014, 00:00

  • Type of Multimorbidity and Patient-Centered Care Among Elderly Medicare Beneficiaries

    Nov 1, 2014, 00:00

  • An Efficient Design for Cost-Effectiveness Studies of Personalized Medicine Strategies

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in the Republic of Panama, in Patients with Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel

    Nov 1, 2014, 00:00

  • Effect of A Pharmacy-Based Diabetes Management Program on Glycemic Control in an Inpatient General Medicine Population

    Nov 1, 2014, 00:00

  • The Importance of Sensitivity Analysis in Assessing Clinical and Economic Impact of National Immunization Programs- An Example of Slovenia

    Nov 1, 2014, 00:00

  • Price Variation in Obstetrical Services in A Rural State

    Nov 1, 2014, 00:00

  • The Prevalence and Cost of Illness in Women With Endometriosis in Ukraine

    Nov 1, 2014, 00:00

  • Validation of the SPHR Diabetes Prevention Model

    Nov 1, 2014, 00:00

  • Health-Economic Comparison of Sensor-Augmented Pump With Low Glucose Suspend Versus Insulin Pump Alone For The Treatment Of Hypo-Prone Type 1 Diabetes In Slovakia

    Nov 1, 2014, 00:00

  • Burden of Non-Adherence To Type 1 Diabetes Mellitus Therapeutic Guidelines In France

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Analysis for Hiv Treatment Alternatives in Turkey

    Nov 1, 2014, 00:00

  • Health Care Costs in Patients With Type 2 Diabetes in Flanders Based on A Combination of Clinical And Health Insurance Data

    Nov 1, 2014, 00:00

  • Economic Impact of New Rural Cooperative Medical Scheme In China

    Nov 1, 2014, 00:00

  • Pro Claims In Orphan Medicines Approved By the European Medicines Agency (Ema) for the Treatment of Lymphoproliferative Disorders

    Nov 1, 2014, 00:00

  • A Systematic Literature Review of the Humanistic Burden of Multiple Myeloma

    Nov 1, 2014, 00:00

  • Assessing Willigness to Pay Among Psoriasis and Psoriatic Arthritis Patients

    Nov 1, 2014, 00:00

  • Logistics of Monitoring of Vitamin K Antagonists in Western European Countries- Prefer in Vte Registry

    Nov 1, 2014, 00:00

  • Mapping European Database Usage- An Analysis of Published Data Types

    Nov 1, 2014, 00:00

  • COUGH AS A KEY SYMPTOM IN ASTHMA, ALLERGIC RHINITIS, COPD AND RHINOSINUSITIS AND ITS IMPACT IN ASIA

    Nov 1, 2014, 00:00

  • Potential Epidemics of Drugs Resistant Bacteria in Poverty Stricken Countries Like Pakistan

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Ugt1a1 Genotyping Before Colorectal Cancer Treatment with Irinotecan

    Nov 1, 2014, 00:00

  • Quality of Life in Patients With Lung Cancer in the Slovak Republic

    Nov 1, 2014, 00:00

  • Reality in Market Access In Germany and France – Comparative Analysis of Added Benefit Decisions on Innovative Pharmaceutical Therapies

    Nov 1, 2014, 00:00

  • Pharmacoepidemiology of Cellular/Tissue Derived Products for the Treatment of Venous Leg Ulcers in Outpatient Care Settings

    Nov 1, 2014, 00:00

  • Social Contacts Reduce Negative Symptoms, Especially Emotional Withdrawal in Patients with Schizophrenia

    Nov 1, 2014, 00:00

  • Adoption of Oral Disease Modifying Treatments to Manage Patients with Relapsing Remitting Multiple Sclerosis from 2011-2013 in the United States

    Nov 1, 2014, 00:00

  • Determination of Cost-Effectiveness Threshold For Malaysia

    Nov 1, 2014, 00:00

  • Health Care Reform in China And The United States- A Tale of Two Nations Seeking To Improve Access To Affordable Coverage

    Nov 1, 2014, 00:00

  • How Iranian People Think About Generic Substitution?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Surgical Management of Stress Urinary Incontinence With Single-Incision Mini-Sling Versus Tension-Free Vaginal Obturator in Spain

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Everolimus for the Treatment of Hormone Receptor Positive, Human Epidermal Growth Factor Receptor-2 Negative (HER2-) Advanced Breast Cancer in Kazakhstan

    Nov 1, 2014, 00:00

  • The Reliability and Validity of the Chinese Version of the Eight-Item Morisky Medication Adherence Scale

    Nov 1, 2014, 00:00

  • Epidemiology of Patients with Metastatic Castrate Resistant Prostate Cancer in Europe and Australia

    Nov 1, 2014, 00:00

  • Physicians' and Patients' Preferences Over the Attributes of Biological Agents Used In the Treatment of Rheumatic Diseases In Spain- A Conjoint Analysis

    Nov 1, 2014, 00:00

  • Health Care Costs and Utilization of U. S. Veteran Patients Diagnosed with Pancreatic Cancer

    Nov 1, 2014, 00:00

  • Strategies To Overcome Hurdles In Hta Appraisals Amid Limitations Resulting From Single-Arm Trial Data

    Nov 1, 2014, 00:00

  • Impact Of A Pharmacological Cardioversion With Vernakalant On The Management Cost Of Recent Atrial Fibrillation In Belgium

    Nov 1, 2014, 00:00

  • Review Of Reference Pricing Effects On Pharmaceuticals

    Nov 1, 2014, 00:00

  • Over the Counter Medication and Dietary Supplements Use Among Older Adults

    Nov 1, 2014, 00:00

  • The Clinical Evidence Base of Treatment Options in Alzheimer's Disease- A Systematic Literature Search

    Nov 1, 2014, 00:00

  • Comparative Efficacy and Safety of Empagliflozin with Other Antidiabetic Drugs for the Third Line Treatment of Type 2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Awareness of Breast Cancer and its Prevention. A Comparative Survey Among Finnish and Hungarian Women

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of the Use of Crizotinib for Non-Small Cell Lung Cancer and ALK+ Mutation in the Two Main Public Health Care Institutions in Mexico

    Nov 1, 2014, 00:00

  • Economic Impact of a Genomic Companion Diagnostic Test for Breast Cancer Patients in French Private Hospitals

    Nov 1, 2014, 00:00

  • Cost Comparison of Surgical and Non-Surgical Treated Lumbar Spinal Stenosis Patients

    Nov 1, 2014, 00:00

  • Treating Verse Non-Treating Obsturictive Sleep Apnea in Italy and Fran A Markov Model-Based Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Knowledge Transfer Gap Between Cardiologists and Patients Undergoing Percutaneous Coronary Intervention Regarding Risks Associated With Drug-Eluting Stents- An Asian European Survey

    Nov 1, 2014, 00:00

  • Development Of An Influenza Outbreak Forecasting Model Using Time Series Analysis Methods

    Nov 1, 2014, 00:00

  • The Burden of Myelofibrosis In Greece

    Nov 1, 2014, 00:00

  • Feasibility of Conducting Retrospective Studies Using Hashtags and Social Media Data From Facebook and Twitter

    Nov 1, 2014, 00:00

  • Sagit©- A Novel Clinician-Reported Outcome for Managing Acromegaly in Clinical Practice

    Nov 1, 2014, 00:00

  • Organization Potency and Human Resource

    Nov 1, 2014, 00:00

  • Literature Review of Decision-Analytical Models Used in the Economic Evaluation of Empirical/Targeted Antifungal Treatments for Invasive Fungal Infections

    Nov 1, 2014, 00:00

  • Impact of Allergen Immunotherapy on Quality of Life and Health Care Costs in Adults and Children With Grass Pollen-Induced Allergic Rhinitis in Germany

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Apixaban Compared To Other Anticoagulants For Lifetime Treatment And Prevention Of Recurrent Venous Thromboembolism

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Simeprevir With Peginterferon + Ribavirin (SMV/PR) in the Management of Genotype 1 (G1) and 4 (G4) Hepatitis C Virus (HCV) Infection; from the Perspective of the Uk National Health Service (NHS)

    Nov 1, 2014, 00:00

  • Adherence to Nice Guidance For Initiating Glp-1 Mimetics Among Patients With Type 2 Diabetes In Primary Care In England And Wales - An Evaluation Using The Clinical Practice Research Datalink (Cprd)

    Nov 1, 2014, 00:00

  • Mast (Minimal Access Spinal Technologies) Versus Open Surgery- Cost Analysis From Hospital Perspective

    Nov 1, 2014, 00:00

  • Evaluation of Use of Belimumab In Clinical Practice Settings (Observe Study) In Spain- Health Resource Utilization and Labour Absenteeism

    Nov 1, 2014, 00:00

  • What's the optimal visual inspection screening intervals for cervical cancer screening in real practice of rural china? A cost-utility modeling study

    Nov 1, 2014, 00:00

  • Minimum Clinically Important Difference in the Global Assessment Functioning in Patients with Schizophrenia

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Evaluation of Biologic Therapies in Russian Patients With Rheumatoid Arthritis and Intolerance or Inadequate Response to Conventional Basic Therap

    Nov 1, 2014, 00:00

  • Workflow Mapping for Paediatric Vaccination Process in the United Kingdom (Uk)- A Precursor of A Time and Motion (TM) Study

    Nov 1, 2014, 00:00

  • Health Related Quality Of Life At One Year Post Discharge In Patients With Heart Failure

    Nov 1, 2014, 00:00

  • Clinical Effectiveness of Fumaric Acid Esters (Fumaderm) in Psoriasis- A Systematic Review of Literature

    Nov 1, 2014, 00:00

  • Oncology Products in the Amnog Process – Learnings for a Successful Dossier Submission

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Subcutaneous Verse Intramuscular Interferon Beta-1A In Portugal Based on the Findings of Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Chewing a Gum- Effect on Saliuvation, Passing out of Flatus, Bowel Movement and Gastric Motility Among Filipino Elderly

    Nov 1, 2014, 00:00

  • Implementation of International Chart Review Studies- An Assessment of Ethics and Regulatory Considerations

    Nov 1, 2014, 00:00

  • Understanding The Role of Subgroup Analysis And Tests For Homogeneity or Interaction in the Amnog Dossier

    Nov 1, 2014, 00:00

  • A Reliability Generalisation of the Eortc Qlq-Br23

    Nov 1, 2014, 00:00

  • Drugs in Constraint Countries of Sub Saharan Africa

    Nov 1, 2014, 00:00

  • Impact of Omalizumab on Poor Asthma Control Events and Medication Utilisation in Patients With Moderate or Severe Persistent Asthma

    Nov 1, 2014, 00:00

  • Goal Attainment Scaling – A Useful Individualized Clinical Outcome Measure

    Nov 1, 2014, 00:00

  • A Quantification of Expenditure on Hospital Stays In 5 European Countries

    Nov 1, 2014, 00:00

  • Negative Reimbursement Consequences From Trial Design Choices

    Nov 1, 2014, 00:00

  • A Comparison of Market Access Evaluations for new Oncology Therapies in France, Germany and the UK- An Analysis Using the Prismaccess Database

    Nov 1, 2014, 00:00

  • The Burden of Parkinson Disease Amongst Caregivers in Spain Over 4 Years

    Nov 1, 2014, 00:00

  • The Societal Costs of Schizophrenia in Switzerland

    Nov 1, 2014, 00:00

  • Family Preferences in the Volume Verse Outcome Debate- Implications for the Delivery of Complex Pediatric Care

    Nov 1, 2014, 00:00

  • Methodological Requirements Regarding Quality of Life Measurement in the Early Assessment of Benefit In Germany

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI) in Sweden

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in Croatia National Vaccination Program

    Nov 1, 2014, 00:00

  • Value of Life And Cost of Pre-Mature Deaths With the Perspective of Productivity As Net Tax Revenue for Turkey

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of First-Line Regimen Between Cisplatin Plus Pemetrexed and Carboplatin Plus Paclitaxel In Advanced Non-Squamous Non-Small-Cell Lung Cancer in Thailand

    Nov 1, 2014, 00:00

  • Economic Impact of the Inclusion of Pertuzumab for the Treatment of Metastatic Breast Cancer HER2 +

    Nov 1, 2014, 00:00

  • Redel Study- Differences in Reimbursement Delays in Cee Countries

    Nov 1, 2014, 00:00

  • Men's Preferences For The Treatment Of Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (Bph)- A Discrete Choice Experiment (Dce)

    Nov 1, 2014, 00:00

  • Patient Preferences in the Choice of Disease Modifying Anti-Rheumatic Drugs

    Nov 1, 2014, 00:00

  • Different Strategies for Latent TB Assessment in Patients Undergoing Anti-TNF Treatment- an Economic Model

    Nov 1, 2014, 00:00

  • The Irish Cost-Effectiveness Threshold- Does It Support Rational Rationing or Might It Lead To Systematic Damage Of Ireland's Health System?

    Nov 1, 2014, 00:00

  • Health Economic Impact of Volume Doubling Time as Biomarker in Lung Cancer Diagnosis

    Nov 1, 2014, 00:00

  • Ldl-C Goal Attainment In Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden

    Nov 1, 2014, 00:00

  • Alzheimer's Disease Caregiver Burden in Japan and the 5 E.U

    Nov 1, 2014, 00:00

  • Monitoring Antiretroviral Therapy in Uganda- Budget Impact Analysis of Two Strategies for Viral Load Monitoring Versus Immunologic Monitoring

    Nov 1, 2014, 00:00

  • Impact of Hepatitis B on Human Immunodeficiency Virus Patients in Malaysia- A Retrospective Study

    Nov 1, 2014, 00:00

  • Archimedes- A Large Scale Simulation System for Health Care Research and its Applications for Asian Countries

    Nov 1, 2014, 00:00

  • Incidence-Based Cost of Asthma in Vietnam

    Nov 1, 2014, 00:00

  • Restless Leg Syndrome Detection in Hemodialysis

    Nov 1, 2014, 00:00

  • Cost Utility Of Diabetes Drugs Using Hba1c As A Direct Predictor For Quality Of Life, Diabetes Complications And Mortality

    Nov 1, 2014, 00:00

  • Prospective Study on Quality of Life (QOL) of Bronchial Asthma Patients in a Tertiary Care Teaching Hospital

    Nov 1, 2014, 00:00

  • Cardiovascular Risk, Gender And Medication Adherence In Rural Area Of Vietnam

    Nov 1, 2014, 00:00

  • Testing The Utility Of The Nhs's Systemic Anti-Cancer Therapy Data Set For Multi-Indication Pricing

    Nov 1, 2014, 00:00

  • Assessing Consistency in a Network Meta-Analysis to Compare Once Weekly Dulaglutide Versus Other Glp-1 Receptor Agonists in Patients with Type 2 Diabetes

    Nov 1, 2014, 00:00

  • Use of Services and Cost of Agitation and Containment in Psychiatric Hospitals- a Systematic Review

    Nov 1, 2014, 00:00

  • Tadalafil in Benign Prostatic Hyperplasia- Protocol for the Systematic Review of Adverse Events

    Nov 1, 2014, 00:00

  • Pollen Morphology and Total Protein of Taraxacum Officinale and Aster Alpinus

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Osteoporosis Screening and Treatment Strategy in the Elderly Japanese Women

    Nov 1, 2014, 00:00

  • Costs of Psoriasis in Europe. A Systematic Review of the Literature

    Nov 1, 2014, 00:00

  • Cost Effectiveness Analysis Evaluating Factor Viii As Primary Prophylaxis Treatment for Patients With Severe Haemophilia A In the Netherlands

    Nov 1, 2014, 00:00

  • A Review Of Cost Of Illness Studies In Patients With End Stage Renal Disease

    Nov 1, 2014, 00:00

  • Combining Headroom and Return on Investment Analysis To Rank Potential Commercial Value of Six Medical Devices in Development

    Nov 1, 2014, 00:00

  • Effect Of Sample Size And Data Maturity On Parametric Survival Modeling Projections In Advanced Cancer

    Nov 1, 2014, 00:00

  • Reimbursement Trends and Evidence Requirements for Ultra-Orphan Therapies Across Europe- Optimising Market Access in Increasingly Challenging Markets

    Nov 1, 2014, 00:00

  • The Economic Burden of Systemic Lupus Erythematosus- A Structured Literature Review

    Nov 1, 2014, 00:00

  • Pharmacoeconomics Evaluation Of Clinical Pharmacy Service For Diabetic Inpatients

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (COPD)- Cross-Model Comparison of Hypothetical Treatment Scenarios

    Nov 1, 2014, 00:00

  • Amnog Benefit Assessment for Oncologic and Orphan Drugs in Germany – Implications for Price Discounts

    Nov 1, 2014, 00:00

  • Economic Assessment of Preeclampsia- Screening, Diagnosis, Treatment Options, and Long Term Outcomes, A Systematic Review

    Nov 1, 2014, 00:00

  • Psychometric Properties of the 16-Item Sort form Version of the Menopause Cervantes Health-Related-Quality-of-Life Scale- the Cervantes-Sf

    Nov 1, 2014, 00:00

  • Targeted Literature Review Of Unmet Need In The Hyperlipidaemia Population With High Risk Of Cardiovascular Disease

    Nov 1, 2014, 00:00

  • Efficacy Of Add – On Vildagliptin Therapy To Metformin For Type Ii Diabetes Mellitus Patients In South Indian Resource Limited Settings – Pilot Study

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Saxagliptin Compared To Glp-1 Analogues As An Add-On To Insulin in the Treatment of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

    Nov 1, 2014, 00:00

  • The Additional Costs Of Clinical Complications In Patients Undergoing Transcatheter Aortic Valve Replacement In The German Health Care System

    Nov 1, 2014, 00:00

  • A Comparison of Modelling Techniques- Patient Simulation Verse Markov Modelling in Ophthalmology

    Nov 1, 2014, 00:00

  • The Effect of Dietary Selenium Intake in The Gene Expression of P38, P65, and Caspase-3 in Fluorosis Patients

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Grounding Of Using Polypill Amlodipine With Atorvastatin Versus Monodrugs In Patients With Hypertension And Dyslipidemia In Ukraine

    Nov 1, 2014, 00:00

  • Using Innovative Modeling Analytics with Real World Data to Develop a National Breast Cancer Screening Program in the Kingdom of Saudi Arabia

    Nov 1, 2014, 00:00

  • The Trend of the Prices Of New Marketed Drugs in Turkey

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Bevacizumab- Paclitaxel-Carboplatin (PC) Versus PC in First-Line Therapy of Advanced Non-Small Cell Lung Cancer from Patients' Perspective in Vietnam

    Nov 1, 2014, 00:00

  • Incidence and Prevalence of COPD By Gold 2013 Classification in the Netherlands

    Nov 1, 2014, 00:00

  • Deterministic Versus Stochastic Prediction of Risk for Cardiovascular Events

    Nov 1, 2014, 00:00

  • Network Meta-Analysis of the Relative Efficacy of Pharmacological and Psychological Interventions in Adults with Obsessive Compulsive Disorder

    Nov 1, 2014, 00:00

  • Primary care physicians in an interferon-free world- could safer, more efective oral hepatitis c therapies lead to improved outcomes through education and pcp-prescribed treatment?

    Nov 1, 2014, 00:00

  • Translation and Linguistic Validation of the Electronic Colombia Suicide Severity Rating Scale in Asia-Pac

    Nov 1, 2014, 00:00

  • Systematic Review of Economic Evaluation of Health Technologies Developed In Brazil From 1980-2013

    Nov 1, 2014, 00:00

  • Treatment Continuation and Treatment Characteristics of 3 Long Acting Antipsychotic Medications (Paliperidone Palmitate, Risperidone Microspheres and Haloperidol Decanoate) in Belgium

    Nov 1, 2014, 00:00

  • The Burden of Primary Generalized Tonic-Clonic Seizures in Europe and the United States- An Analysis of The National Health and Wellness Survey

    Nov 1, 2014, 00:00

  • Prospective Study on the Average Cost of Therapy for Bronchial Asthma Patients in an Indian Tertiary Care Teaching Hospital

    Nov 1, 2014, 00:00

  • Predicted Versus Actual Budget Impact of High-Cost Drugs In Ireland

    Nov 1, 2014, 00:00

  • Comparative Study On Health Related Quality Of Life Of Farmers And Workers

    Nov 1, 2014, 00:00

  • Economic Evaluation Studies In Gastroenterology In Brazil- A Systematic Review

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Brentuximab Vedotin in Hodgkin Lymphoma in Sweden

    Nov 1, 2014, 00:00
  • «
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99 (current)
  • 100
  • »